These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 20104932

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL, Aronow HD, Cura FA, Bhatt DL, Albirini A, Schneider JP, Topol EJ, Ellis SG.
    Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
    Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Serebruany VL, Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
    Am Heart J; 2003 Feb; 145(2):239-47. PubMed ID: 12595840
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Stent thrombosis: a poor man's disease?
    Danenberg HD, Marincheva G, Varshitzki B, Nassar H, Lotan C.
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [Abstract] [Full Text] [Related]

  • 30. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL.
    J Am Coll Cardiol; 2005 Mar 15; 45(6):941-6. PubMed ID: 15766833
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G, Yayehd K, Belle L, Thuaire C, Richard P, Cazaux P, Barbou F, Köning R, Chassaing S, Teiger E, Berthier R, Decomis MP, Claudel JP, Delarche N, Brunel P, De Poli F, Dupouy P, Beygui F, Albert F, Collet JP, Montalescot G, VERIFRENCHY investigators.
    Arch Cardiovasc Dis; 2014 Apr 15; 107(4):225-35. PubMed ID: 24794216
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.
    Am Heart J; 2004 Mar 15; 147(3):463-7. PubMed ID: 14999195
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Coronary artery stenting in patients treated by clopidogrel without aspirin.
    Rott D, Leibowitz D, Amit G, Zahger D, Weiss AT.
    Int J Cardiol; 2009 Apr 03; 133(2):279-81. PubMed ID: 18178268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.